G1 Therapeutics, Inc., a clinical-stage oncology company, has officially appointed Barclay (Buck) Phillips as chief financial officer as well as senior vice president of Corporate Development, and Chandra Lovejoy as vice president of Global Regulatory Affairs.   Mr. Phillips joins G1 with more than 25 years of capital markets, financial strategy, and business development experience in life sciences and venture capital. In his most recent role, he served as senior vice president, chief fi...